News
MIDAS platform accelerates protein engineering through rapid PCR-based screening
1+ hour, 41+ min ago (379+ words) Proteins are critical to life " and to industry. There are countless proteins that could be engineered to treat and even cure serious diseases and cellular dysfunctions. Industrial applications are similarly promising, with proteins increasingly used as enzymes in food manufacturing…...
Galux Shows Broadest Target Coverage in Comparative De Novo Antibody Design Study
14+ hour, 49+ min ago (561+ words) Yahoo Finance Oops, something went wrong U. S. markets open in 9h 19m Galux Shows Broadest Target Coverage in Comparative De Novo Antibody Design Study Across nine publicly comparable targets from recent de novo antibody design studies, Galux Design identified experimentally validated binders for…...
Major breakthrough of Sanyou Biopharmaceuticals AI-STAL
17+ hour, 49+ min ago (832+ words) SHANGHAI, May 18, 2026 /PRNewswire/ " Sanyou Biopharmaceuticals announced today that its independently developed AI-STAL has undergone a significant upgrade, successfully achieving a qualitative leap from "molecular treasure trove" to "intelligent engine", marking the company's entry into a new era of intelligence in…...
Galux Outperforms Global Rivals in AI Antibody Design Benchmark
7+ hour, 36+ min ago (344+ words) Compared with Global Antibody Design Platform Studies Secures Binding Antibodies for 8 of 9 Common Targets Galux, an artificial intelligence (AI)-based drug discovery company, said Wednesday that its AI protein design platform "Galux Design" delivered the strongest performance when compared with…...
Tempus AI, Bristol Myers Squibb Expand AI-Driven Clinical Trial Efforts
5+ hour, 18+ min ago (321+ words) Tempus AI Inc. announced a new collaboration initiative with Bristol Myers Squibb Co. aimed at improving clinical trial design and increasing the Probability of Technical & Regulatory Success across five initial development programs. The companies plan to use artificial intelligence, multimodal…...
Codon Optimization Isn't Equal: Benchmarking Gene Design for Antibody Expression
1+ hour, 48+ min ago (83+ words) Credit: Yana Iskayeva / Getty Images In this GEN webinar, Justin Byers and Daniel Lin-Arlow, Ph D, examine how enzymatic DNA synthesis and DNA construct design mitigate antibody expression challenges. Lin-Arlow will present Ansa's enzymatic DNA synthesis technology and the benefits…...
Lighten and Datavant Partner to Deliver Regulatory-Grade EHR Curation for Real-World Evidence Generation
2+ hour, 58+ min ago (562+ words) Bio Space Lighten and Datavant Partner to Deliver Regulatory-Grade EHR Curation for Real-World Evidence Generation Partnership unlocks the full clinical depth of unstructured EHR data at scale, powering high-fidelity analytics for regulatory submissions, natural history studies, and comparative effectiveness research…...
Scientists discover faster way to build new medicines by swapping atoms in molecules
7+ hour, 50+ min ago (79+ words) ...
Protein Engineering and Testing Condensed into One Day
9+ hour, 14+ min ago (1025+ words) Proteins lie at the heart of biological function and industrial innovation, representing a vast frontier for scientific discovery and application. Engineering proteins to enhance or alter their functionality holds enormous promise for treating disease, advancing cellular therapies, and revolutionizing manufacturing…...
Machine Learning Pinpoints Immunotherapy Targets, Validated by Tumor
9+ hour, 56+ min ago (778+ words) In a groundbreaking advancement at the intersection of artificial intelligence and oncology, researchers have unveiled a pioneering method that harnesses machine learning to accelerate immunotherapy drug target discovery. This multidisciplinary approach not only streamlines the identification of promising therapeutic candidates…...